Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase NA 4Phase 4 3Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Classical hematology 3Genitourinary 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Venous Thrombosis × Classical hematology × Clear all
NCT03988231 2021-10-08

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

University of Utah

Phase 4 Withdrawn
Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03006562 2020-08-05

PREVENTER

Johns Hopkins University

Phase 4 Terminated
501 enrolled 13 charts
Classical hematologyGenitourinary

Prostatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed
87 enrolled 9 charts
Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡